Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis

Creative Commons License

URAL U. M., Tekin Y., CURE M., SAHIN F. K.

CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, vol.42, no.4, pp.495-497, 2015 (SCI-Expanded) identifier identifier identifier

Abstract

Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis

By:Ural, UM (Ural, U. Mete)[ 1 ] ; Tekin, YB (Tekin, Y. Bayoglu)[ 1 ] ; Cure, M (Cure, M.)[ 2 ] ; Sahin, FK (Sahin, F. Kir)[ 1 ]

 

CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY

 

Volume: 42

 

Issue: 4

 

Pages: 495-497

Published: 2015

View Journal Information

Abstract

Purpose: To establish serum YKL-40 concentrations in patients with endometriosis compared to age-matched healthy subjects. Materials and Methods: This was a cross-sectional clinical study conducted in a tertiary care center. Demographics and serum YKL levels were determined and noted in a total of 63 cases (33 endometriosis patients, 30 healthy controls). Measurement of YKL-40 levels was made using a YKL-40 enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's protocol. Results: The mean serum YKL-40 levels of the patient group was 106.0 +/- 15.9 (range 23.44 to 382.55) years, while the mean serum YKL-40 levels of the controls was 52.2 +/- 7.0 (range 22.35 to 160.0) years (p = 0.003). Conclusions: This is the first study evaluating serum YKL-40 levels in endometriosis. The present results indicate that YKL-40 levels were increased in patients with endometriosis compared to controls. The authors propose that circulating YKL-40 levels could be a novel biomarker for diagnosis and follow-up of endometriosis.

Keywords

Author Keywords:Endometriosis; Serum; YKL-40 levels; Marker

KeyWords Plus:ENDOTHELIAL GROWTH-FACTOR; MACROPHAGE DIFFERENTIATION; OVARIAN-CANCER; ANGIOGENESIS; GENE; CHI3L1; WOMEN

Author Information

Reprint Address: Ural, UM (reprint author)

Recep Tayyip Erdogan Univ, Fac Med, Dept Obstet & Gynecol, Islampasa Mahallesi,Sehitler Caddesi 74, Rize, Turkey.

 

Addresses:

Purpose: To establish serum YKL-40 concentrations in patients with endometriosis compared to age-matched healthy subjects. Materials and Methods: This was a cross-sectional clinical study conducted in a tertiary care center. Demographics and serum YKL levels were determined and noted in a total of 63 cases (33 endometriosis patients, 30 healthy controls). Measurement of YKL-40 levels was made using a YKL-40 enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's protocol. Results: The mean serum YKL-40 levels of the patient group was 106.0 +/- 15.9 (range 23.44 to 382.55) years, while the mean serum YKL-40 levels of the controls was 52.2 +/- 7.0 (range 22.35 to 160.0) years (p = 0.003). Conclusions: This is the first study evaluating serum YKL-40 levels in endometriosis. The present results indicate that YKL-40 levels were increased in patients with endometriosis compared to controls. The authors propose that circulating YKL-40 levels could be a novel biomarker for diagnosis and follow-up of endometriosis.